treating indolent and mantle cell lymphoma: results of the bright 5 year follow up study
Published 7 years ago • 591 plays • Length 3:01Download video MP4
Download video MP3
Similar videos
-
5:06
trials of interest in the mantle cell lymphoma space at ash 2023
-
1:24
treatment methods in mantle cell lymphoma
-
1:36
indolent lymphoma treatment in the us vs. europe
-
1:43
the role of targeted therapies in the frontline treatment of mantle cell lymphoma
-
1:22
diagnostics and treatment outcomes from primary cbcl
-
0:54
zilovertamab vedotin in the treatment of mantle cell lymphoma
-
40:47
mantle cell lymphoma
-
1:17:38
mantle cell lymphoma survivor shares story | the patient story ft. tim holyoake | the patient story
-
9:25
mgus diagnosis: a step-by-step approach
-
0:46
is there potential for the use of combination therapies in sickle cell disease?
-
1:59
assessing if a patient with dlbcl is responding to treatment using pet-ct and novel assays
-
1:44
treating mantle cell lymphoma: past approaches and future perspectives
-
0:58
therapies under investigation for mantle cell lymphoma
-
5:50
venetoclax and r2 in mantle cell lymphoma
-
2:40
the current standard of care in mantle cell lymphoma
-
2:09
the optimal sequencing of novel therapies in mantle cell lymphoma
-
1:18
real-world outcomes of patients with mantle cell lymphoma
-
1:37
watch and wait: defining the indolent patient group in mcl
-
1:43
ongoing clinical trials to look out for in lymphoma
-
2:22
the need for novel agents to treat patients with mcl who have relapsed after targeted therapy
-
1:33
developing mantle cell lymphoma treatment for further success